Relapsing fever (RF) is caused by tick-and louse-borne Borrelia spp., is characterized by recurrent fever, and is often misdiagnosed as malaria. Because of submicroscopic bacteremia, microscopy can be insensitive between febrile bouts. We designed a multiplex quantitative PCR (qPCR) assay to distinguish RF Borrelia from Plasmodium falciparum and P. vivax. The assay specifically (100%) amplified pathogenic RF Borrelia (1 copy/reaction). We then tested blood from participants within a Tanzanian cohort assessed at scheduled intervals and with fever. Among 8,617 blood samples from 2,057 participants surveyed routinely, 7 (0.08%) samples and 7 (0.3%) participants had RF DNA (median, 4.4 ؋ 10 3 copies/ml). Of 382 samples from 310 febrile persons, 15 (3.9%) samples from 13 (4.2%) participants had RF DNA (median, 7.9 ؋ 10 2 copies/ml). Five (1.3%) samples from 4 (1.3%) participants were found to harbor Borrelia by microscopy. We conclude that multiplex qPCR holds promise for improved clinical diagnosis and epidemiologic assessment of RF.Relapsing fever (RF) is an acute febrile illness caused by multiple Borrelia species, which differ by geographic location and are transmitted either by argasid (soft body) ticks or by human body lice. Fever recurs over weeks or months as Borrelia alters surface antigens, immune system escape occurs, and new waves of bacteremia with Յ10 6 bacteria/ml ensue (2, 7, 26). The sensitivity of Giemsa-stained peripheral blood smear analysis is limited for low-level bacteremia, and the technique is not useful during asymptomatic intervals. Microscopy is impractical for large studies and cannot accurately assess disease burden. Therefore, we developed a high-throughput, real-time multiplex quantitative PCR (qPCR) assay to detect RF Borrelia, Plasmodium falciparum, and P. vivax to support a large clinical trial in Tanzania. Herein we report diagnostic and epidemiological findings related to identification of RF Borrelia among trial participants.
MATERIALS AND METHODSParticipants. (i) Setting. We sought to identify incidents of symptomatic and asymptomatic relapsing fever as an ancillary study to that of mass treatment with azithromycin for trachoma (Partnership for the Rapid Elimination of Trachoma [PRETϩ]). In the parent study, four villages in the Kongwa district in the central Dodoma region of Tanzania were selected for WHO-recommended single-dose mass treatment with azithromycin (20 mg/kg of body weight, up to 1 g) for highly prevalent (Ն10%) active (trachomatous follicular or intense) trachoma (17,21,25). Within villages, 130 households per village (intervention group) were randomly selected. Within households, children Ͻ7 years of age, caregivers, and pregnant women were eligible; one child and one caregiver were randomly selected in addition to pregnant women. Four otherwise similar villages in the same geographic area with less-prevalent active trachoma (Ͻ10%) were chosen as controls. Enrollment was per the intervention group.(ii) Routine surveillance. Young children (0 months to 7 years of ...